Precursor B-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Precursor B-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults. [Phase 2]
Phase 2 study in adults with precursor B-cell acute lymphoblastic leukemia adds blinatumomab to prephase and consolidation therapy.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
Phase 2 study evaluating daratumumab for relapsed/refractory precursor B-cell or T-cell acute lymphoblastic leukemia and lymphoblastic lymph…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma [Phase 2]
Phase 2 clinical trial update for a pediatric therapy in relapsed or refractory precursor B-cell acute lymphoblastic leukemia and lymphoma; …
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: MB-CART19.1 in Patients With R/R ALL [Phase 2]
This document notes a Phase 2 clinical trial evaluating MB-CART19.1 in patients with refractory precursor B-cell acute lymphoblastic leukemi…